Half-year report · Q2
3840.TEDINET S100USGE
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | −¥84m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | −¥116m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | −¥78m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | −¥168m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥114m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥79m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | −¥101m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥176m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥82m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | −¥104m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥2.1bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥1.5bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥694m | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥477m | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.4bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥190m | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥297m | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥190m | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥238m | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥173m | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥248m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥77m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥54m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥432m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥87m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥573m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥288m | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥126m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.38 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.31 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.9% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 32
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥59m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥500m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥500m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥10m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥439m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥439m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥181m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥181m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥9m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥29m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥1.1bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥40m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥538m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥538m |
| jpcrp040300-q2r_E05674-000Beauty And Wellness Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥16m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥395m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥395m |
| jpcrp040300-q2r_E05674-000Cosmetics Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥56m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥168m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥168m |
| jpcrp040300-q2r_E05674-000Regenerative Medicine Related Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3m |
| jpcrp040300-q2r_E05674-000Sustainable Businessreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥37m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥1.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | −¥76m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 489
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBusinessReportableSegmentsMember | 439488000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | 500413000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | 180806000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | 3203000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1123910000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 1123910000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBusinessReportableSegmentsMember | 439488000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | 500413000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | 180806000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | 3203000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 1123910000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 1123910000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05674-000CosmeticsBusinessReportableSegmentsMember | 2387000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05674-000BeautyAndWellnessBusinessReportableSegmentsMember | 9964000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05674-000RegenerativeMedicineRelatedBusinessReportableSegmentsMember | -9438000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E05674-000SustainableBusinessReportableSegmentsMember | -28517000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -25603000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | -58505000 | JPY |
| Operating income | CurrentYTDDuration | -84109000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-11-14 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第35期中（自 2024年４月１日 至 2024年９月30日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Company name in english cover page | FilingDateInstant | PATH corporation | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 高橋 勇造 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都渋谷区神宮前六丁目17番11号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03（6823）6664（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05674 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 38400 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Filer name in english | FilingDateInstant | PATH corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |